In this paper we describe a simple ion Chromatographie method for determination of oxalate in urine. Acidified urine was diluted 1 : 2 with 0.03 mol/1 benzidine hydrochloride in 0.3 mol/1 boric acid to precipitate sulphate. The supernatant was passed through a C 18 -cartridge and 100 μΐ of eluant were injected into an ion Chromatographie system. Oxalate was measured by nonsuppressed conductivity detection. The detection limit for urinary oxalate was 0.05 mmol/1. The recovery for spiked urine samples was 101.5% with a CV of 4.5%. The within-and between-assay coefficients of variation were less than 4.5% and 2.5%, respectively. We found the results obtained by this method to be statistically equivalent to an enzymatic assay and a different ion-chromatographic method.
Introduction
Urolithiasis is still a widespread disease. Almost 70% of the renal stones consist of two forms of calcium oxalate (1) . In addition to the stone analysis, the reliable analysis of oxalate in body fluids, especially in urine, is of great importance for the diagnosis and adequate metaphylaxis of calcium oxalate urolithiasis. In the last thirty years many methods for the determination of urinary oxalate have been developed (2, 3) . The most applied procedures are colorimetric methods (4, 5) , fluorometry (6) , atomic absorption spectrophotometry (7), gas chromatography (8, 9) , isotope dilution (10, 11) , enzymatic methods using oxalate oxidase 2 ) (12, 13, 15) or oxalate decarboxylase 2 ) (14, 15) , isotachophoresis (8) , and highperformance liquid chromatography (HPLC), especially ion chromatography (13, (16) (17) (18) (19) (20) (21) (22) . In the last decade both the colorimetric method by Hodgkinson & Williams (4) , which is inaccurate, insensitive, expensive and laborious, and the isotachophoretic method and gas chromatography have been replaced by specific methods like enzymatic procedures and HPLC-techniques.
The ion Chromatographie techniques usually apply suppressed conductivity detection of the oxalate ion, although for the oxalate determination in urine, suppression is not required with respect to sensitivity. We describe a simple oxalate assay using ion chromatography with non-suppressed conductivity detection after removal of sulphate. The Chromatographie technique, analytical conditions and its clinical application are reported in this paper.
Materials and Methods

Equipment
The Chromatographie system consisted of an HPLC-pump (WATERS 510, Waters Chromatography Division, USA), an autosampler (WATERS WISP 712) with variable sample loop, a nonsuppressed conductivity detector (WATERS 431) and an analytical anion-exchange column (WATERS 1C pak anion high capacity, 4.6 X 140 mm, 10 μηι particle size). Chromatograms were recorded on an integrator (WATERS Data Module 746). For sample cleanup SepPak Ci 8 -plus cartridges (360 mg packing material, 55-105 μηι particle size, Millipore Corp., USA) were used.
Reagents
Boric acid, sodium tetraborate decahydrate, glycerin, n-butanol, acetonitrile, hydrochloric acid (300 g/kg, about 8 mol/1), ammonium sulphate and ammonium oxalate were obtained from E. Merck (Darmstadt, Germany); sodium gluconate was purchased from Sigma (SIGMA Chemical Co., USA) and benzidine dihydrochloride from Fluka (Fluka Chemie AG Buchs, Switzerland). All reagents used were of analytical grade and all solvents were of HPLC-grade. The 0.03 mol/1 benzidine dihydrochloride/0.3 mol/1 boric acid solution was prepared daily. The stock solution of ammonium oxalate had a concentration of 0.025 mol/1 and was storable up to one week. The standards were freshly prepared by dilution of the 25 mmol/1 oxalate stock solution, addition of HC1 (10 ml 8 mol/1 per litre solution), and addition of 20 mmol/1 sulphate. A 0.05 mol/1 ammonium sulphate stock solution was prepared for precipitation experiments.
Preparation of urine samples 24-h urines were collected in polyethylene bottles containing 15 ml concentrated hydrochloric acid (300 g/kg) for preservation and to obtain pH values < 2.0. A 3 ml aliquot of the urine was diluted with 3 ml of a 0.03 mol/1 benzidine dihydrochloride solution (CAUTION: highly carcinogenic) in 0.3 mol/1 boric acid, agitated, and filtrated. A reversed phase C 18 -cartridge was activated by passing 2 ml methanol and 4 ml aqua dest. The first millilitre of the urine sample was rejected and the following 3 ml were collected in a 4 ml vial. 
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Chromatographie conditions
The mobile phase was a borate-gluconate buffer containing 1.47 mmol/1 sodium gluconate, 5.82 mmol/1 boric acid, 1.31 mmol/1 sodium tetraborate decahydrate, 5 ml/1 glycerol, 120 ml/1 acetonitrile and 20 ml/1 «-butanol. The eluant had a pH value of 8.5 and its conductivity was 275 μ8. The flow rate was 2 ml/min. The elu-ant was degassed by vacuum filtration through a membrane filter (0.5 μιη, Millipore Corporation, USA). The detector sensitivity was set to 0.1 S f ll scale. Pretreated sample material (100 μΐ) was injected onto the column. The retention time of oxalate was 27 minutes at a constant column temperature of 26 °C. Oxalate was quantified via peak area and external standards.
The separation column gave reproducible retention times up to 650 injections. After that period a regeneration with 100 ml of twofold concentrated eluant with a low flow rate < 1.0 ml/min was necessary. After approximately 800 injections the column should be replaced.
Results and Discussion
The acidification of the urine samples during collection is often applied. First of all it prevents oxalate precipitation. Second it delays the formation of oxalate from ascorbate (13, 26) . Furthermore, combined with storage at -18 °C it is a way of preservation (25) .
The interaction of the oxalate peak with the sulphate peak is the main problem with all anion exchange columns currently available. This interaction increases the determination limit and disturbs the accurate evaluation of the oxalate peak area. Experiments to obtain a better separation of sulphate and oxalate by variation of the strength of the eluting solvent, the flow rate or the temperature of the column gave unsatisfying results. Series of measurements applying solutions with 0.2 mmol/1 of oxalate and varying sulphate concentrations from 5-35 mmol/1 were performed.· These measurements showed that 20 mmol/1 of sulphate results in deviated oxalate values. Therefore, it was neccessary to eliminate the sulphate.
The first attempts of sulfate precipitation with barium chloride as suggested by Toyoda (22) were not successful because of a simultaneous precipitation of oxalate in the above mentioned concentration range. Another insoluble sulphate salt is benzidine sulphate (24) . A comparable insoluble oxalate compound should not be formed under the applied reaction conditions. To investigate this fact aqueous solutions and urines were treated with aqueous benzidine dihydrochloride solutions with different concentrations to find the optimal concentration for the quantitative precipitation of sulphate. We assumed an average physiological concentration of 20 mmol/1 urinary sulphate. The results of these experiments confirmed that the oxalate is not influenced if urines are diluted with benzidine dihydrochloride solutions with a concentration of 30 mmol/1 in the ratio 1 : 1. To examine the dependency of sulphate precipitation on the pH value we tested urines with pH values ranging from 1 -8. We found that pH values ranging from 1-3 were optimal for the sulphate precipitation and oxalate recovery. A typical chromatogram before and after precipitation of sulphate is shown in figure 1 .
For the prevention of the oxalate formation from ascorbate by alkaline pH values during the measurements the urines were diluted with 0.3 mol/1 boric acid solution as suggested (13, 26) . Boric acid is part of the mobile phase and the pH value of the eluant used was 8.5 in comparison to pH 10 of the widely used carbonate/ hydrogencarbonate buffer (13, 17) . The steps of dilution with boric acid and the addition of benzidine dihydrochloride were combined by dissolving the benzidine dihydrochloride in 0.3 mol/1 boric acid solution.
Other interfering phenomena with ions occuring in urine were not found. This was tested by adding halogenides, phosphates, ascorbate, glyoxylic acid, glycolic acid, and citric acid to acidified standard solutions in physiological concentrations (23) . The calibration curve for the quantitative determination of oxalate was established by using aqueous standard solutions with concentrations ranging from 0.05-1.0 mmol/1. The standards were pretreated and analyzed analogously to the procedure described for urine samples. The peak area increases linear with the oxalate concentration in the range of from 0.05 mmol/1 to 1.0 mmol/1. This range is sufficient, since 98% of all urine samples are found in this region. The detection limit for urinary oxalate was 0.05 mmol/1. To characterize the analytical conditions of the method we evaluated the recovery of oxalate added and the within-run and between-batch precision. To determine the recovery we measured the urines before and after spiking with oxalate. Oxalate was added to four urines to obtain an additional oxalate concentration of 0.1, 0.2, 0.3, 0.4, and 0.5 mmol/1, respectively. All 20 samples were measured twice. In the range from 0.1 to 1.0 mmol/1 oxalate we found a mean recovery of 101.5% with a CV of 4.5%. Figure 2 shows the recovery results by comparison of expected and measured oxalate concentration.
For the investigations of between-batch precision three urines with low, middle and high oxalate concentrations were measured twice a day over the course of 10 days. Additionally, the oxalate concentration of the same urine sample was determined twenty times to gain information about within-run precision. The means of oxalate concentration and the CV are summarized in table 1. These investigations delivered accurate results with oxalate concentrations ranging from 0.1 mmol/1 to 1.0 mmol/1. The CV was best at high and According to Passing & Bablok (27, 28) we compared the method described, a different ion Chromatographie method with a more basic eluant and chemical background supression (13), and a commercial enzymatic kit (Sigma Chemical Co., product No. 591) using oxalate oxidase (13) . This was performed by measuring 80 different urines from healthy subjects and calcium oxalate stone formers (Department of Urology, University of Bonn) with each of the methods. Figures 3 and 4 show the correlation between the three methods compared (regression parameter enzymatic kitunsuppressed ion chromatography). The comparison of methods showed statistically identical results for all three methods. Because of the convenience of the method described, it is possible to measure up to 40 samples per day.
The calculation of cost depends on the amount of samples that are to be analyzed. The estimated sample-independent charge for the enzymatic method is about 7 US$ (material, working time, overhead). Not included in this calculation is the purchase of a photometer, because it is available in most laboratories. The estimated charges for a suppressed and a non-suppressed ion Chromatographie analysis of oxalate (including purchase, maintenance, and depreciation of the Chromatographie system) are about 5 US$ and 4 US$. The calculations for the Chromatographie system are based on a throughput of about 3500 samples/year for 5 years. The higher expenses for the suppressed system are due to the reduced variety of suppressor devices and/or suppressed Chromatographie systems.
Conclusions
The HPLC-method for the determination of urinary oxalate is accurate. The results with regard to quality were excellent and the method is simple to perform. All analytical tests gave accurate results and the method is very reliable. A comparison with two different well-established procedures showed good correlations. The problem of interfering sulphate was solved by using a new and uncomplicated procedure of almost quantitative precipitation of sulphate using benzidine dihydrochloride. An advantage of the employed system over other ion Chromatographie methods is the use of a borate buffer as mobile phase with pH value of 8.5. This reduces the risk of oxalogenesis from ascorbate. Furthermore, the method can be adapted to every existing HPLC system.
